RxDoctor Payments Data

Jimmy Hewitt, DO

Family Medicine · North Augusta, SCNPI 1558334144

Payments from drug & device makers

$270in general payments, 2019–2025

Across 15 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$109
  • Pfizer$40
  • Merck$33
  • Boston Scientific$31
  • Scilex Pharmaceuticals Inc.$24
  • Abiomed$19
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$270100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$270 in reported general payments places this provider in the 40th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$145,466
Medicare patients
248
Services billed
3,937

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide113$161,034
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$74,623
JanuviaSitagliptin Phosphate53$74,231
JardianceEmpagliflozin62$73,595
TrulicityDulaglutide56$69,155
EliquisApixaban68$66,606
FarxigaDapagliflozin Propanediol39$37,743
OzempicSemaglutide25$37,468
Tresiba Flextouch U-200Insulin Degludec15$24,138
Humalog Kwikpen U-100Insulin Lispro19$8,712
InvokanaCanagliflozin12$6,901
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$6,891
MyrbetriqMirabegron13$6,550
Incruse ElliptaUmeclidinium Bromide12$4,850
Breo ElliptaFluticasone/Vilanterol11$4,306

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$33$74,23153 claims
PfizerEliquis$40$66,60668 claims
AstraZenecaFarxiga$14$37,74339 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in North Augusta

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →